Cocrystal Pharma (COCP) Enterprise Value (2010 - 2026)
Cocrystal Pharma (COCP) posted Enterprise Value of -$4.8 million for Q1 2026, up 32.61% sequentially from -$7.2 million in Q4 2025, and up 31.62% YoY from -$3.7 million in Q1 2025.
Cocrystal Pharma (COCP) Enterprise Value (2010 - 2026) Analysis & Trends
Cocrystal Pharma has reported Enterprise Value for 17 years, with the latest figure at -$4.8 million in Q1 2026.
- Quarterly Enterprise Value rose 31.62% year-over-year to -$4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.8 million (up 31.62% YoY) and the FY2025 annual result came in at -$7.2 million, up 28.32% from the prior year.
- Enterprise Value grew to -$4.8 million in Q1 2026 per COCP's latest filing, from -$7.2 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$150000.0 in Q2 2022 and troughed at -$54.8 million in Q1 2022.
- A 5-year average of -$16.3 million and a median of -$10.0 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value soared 99.78% in 2022, then slumped 21562.67% in 2023.
- Over 5 years, Enterprise Value stood at -$37.3 million in 2022, then increased by 28.93% to -$26.5 million in 2023, then soared by 62.23% to -$10.0 million in 2024, then gained by 28.32% to -$7.2 million in 2025, then jumped by 32.61% to -$4.8 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$4.8 million, -$7.2 million, and -$7.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | Cocrystal Pharma | 15.86 Mn | 13.54 Mn | - | -2.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.32 Mn |
| Mar 31, 2026 | -4.84 Mn |
| Dec 31, 2025 | -7.18 Mn |
| Sep 30, 2025 | -7.88 Mn |
| Jun 30, 2025 | -4.84 Mn |
| Mar 31, 2025 | -7.07 Mn |
| Dec 31, 2024 | -10.01 Mn |
| Sep 30, 2024 | -13.17 Mn |
| Jun 30, 2024 | -18.29 Mn |
| Mar 31, 2024 | -21.99 Mn |
| Dec 31, 2023 | -26.50 Mn |
| Sep 30, 2023 | -29.89 Mn |
| Jun 30, 2023 | -32.49 Mn |
| Mar 31, 2023 | -150,000.00 |
| Dec 31, 2022 | -37.29 Mn |
| Sep 30, 2022 | -150,000.00 |
| Jun 30, 2022 | -150,000.00 |
| Mar 31, 2022 | -54.79 Mn |
| Dec 31, 2021 | -58.76 Mn |
| Sep 30, 2021 | -61.58 Mn |